ArticleJournal of asthma and allergy2026
Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong.
Wang Chun Kwok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.